ARTICLE | Company News

Management tracks: TapImmune, Camel-IDS, Arvinas

September 25, 2017 11:58 PM UTC

Immuno-oncology company TapImmune Inc. (NASDAQ:TPIV) named Peter Hoang president and CEO. He was SVP of business development and strategy at Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM).

Cancer company Camel-IDS N.V. (Brussels, Belgium) named Ruth Devenyns CEO, a newly created position. She was CFO at Ogeda S.A., which Astellas Pharma Inc. (Tokyo:4503) acquired...